Mar 10, 2021 | Uncategorized
In October 2020, the Center for Genomic Interpretation (CGI) was awarded funding from the Utah Cancer Genomics Program for “Quality Matters: Recognizing and Assessing Differences in BRCA and Lynch Syndrome Genetic Tests Across Laboratories Most Used by Utah’s...
Mar 10, 2021 | Uncategorized
At the National Society of Genetic Counselors Annual Education Conference, CGI presented a poster on “Calculating and Communicating Error Estimates for Pathogenic Variant Classifications in Germline Sequence Tests.” The poster focused on CGI’s creation of a Positive...
Mar 10, 2021 | Uncategorized
CGI presented its work on how pathogenic variant classifications are not always well-supported by evidence. Working together with genetic counselors from Rocky Mountain Cancer Centers and Texas Oncology, CGI collected de-identified patient reports and examined the...
Mar 10, 2021 | Uncategorized
CGI’s co-founder, Dr. Julie Eggington, and CGI’s ELEVATEGENETICS Standards Committee member, Dr. John Pfeifer, were interviewed by the American Society of Hematology for their article “Demystifying DNA Variant Reporting”, published on December 1, 2020. Dr. Pfeifer...
Mar 10, 2021 | Uncategorized
“Aligning Genetic and Genomic Test Reimbursement With Value of Tests” is an invited article just published in Clinical Laboratory News of the American Association for Clinical Chemistry, authored by CGI’s Drs. Eggington and Garlapow. They summarize issues with...
Recent Comments